<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03415633</url>
  </required_header>
  <id_info>
    <org_study_id>2015-026</org_study_id>
    <nct_id>NCT03415633</nct_id>
  </id_info>
  <brief_title>Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea</brief_title>
  <acronym>APNiA</acronym>
  <official_title>Validity and Cost-effectiveness Analysis of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Araba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BTI Biotechnology Institute S.L</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Investigaci√≥n Sanitaria BIO-ARABA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario Araba</source>
  <brief_summary>
    <textblock>
      To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home
      respiratory polygraphy (HRP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess the diagnostic validity and cost-effectiveness of a APNiA device, a home
      respiratory polygraphy (HRP), performed at home compared with the standard polysomnography
      (PSG) in adults with clinically suspected Obstructive Sleep Apnea (OSA).

      METHODOLOGY: DESIGN: Randomized, prospective, multicenter, and crossover trial. The study
      will include 240 adults, both sexes, with clinical suspicion of obstructive sleep apnea
      (OSA). MEASUREMENTS: To all patients with clinical suspected OSA and referred to the sleep
      units, the following questionnaires and measurements will be performed: a) clinical history;
      b) Anthropometric variables: weight, height, body mass index, neck circumference and
      percentile; c)Epworth sleepiness scale; OSA questionnaire, quality of life and clinical
      questionnaires and comorbidity; d) PSG in the sleep laboratory; e) HRP at home; f)
      Cost-effectiveness variables.

      ANALYSIS: Data from HRP and from full PSG will be compared as follows: 1) Agreement of
      results according to the different apnea-hypopnea index by using the Receiver Operating
      Characteristic (ROC) curve; 2) The concordance of the diagnosis and treatment decisions when
      using clinical findings and data from PSG or HRP at home; 3) All data will be analyzed
      independently; 4) A cost-effectiveness analysis of the different diagnostic and therapeutic
      procedures will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>baseline</time_frame>
    <description>To assess the diagnostic validity of a home respiratory polygraphy (HRP) compared with the standard polysomnography (PSG) in adults with clinically suspected Obstructive Sleep Apnea (OSA), based on the results of the Apnea-hypopnea Index (AHI).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Therapeutic decision</measure>
    <time_frame>6 month</time_frame>
    <description>The concordance of the diagnosis and treatment decision when using clinical findings and data from standard polysomnography (PSG) or home respiratory polygraphy (HRP).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth Sleepiness Scale</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>The Epworth Sleepiness Scale (the sum of 8 items score,0-3) can range from 0 to 24. Scores of 11-24 represent increasing levels of excessive daytime sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STOP-BANG Sleep apnea questionnaire</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Sleep Apnea Questionnaire. High STOP-Bang score indicates a high probability of obstructive sleep apnea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berlin questionnaire</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>The questionnaire consists of 3 categories related to the risk of having sleep apnea. Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories.
High Risk:
if there are 2 or more categories where the score is positive.
Low Risk:
if there is only 1 or no categories where the score is positive.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness analysis</measure>
    <time_frame>6 month</time_frame>
    <description>Cost-efficacy evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Blood pressure measurements: systolic blood pressure and diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric variables (Body mass index)</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (EuroQOL test)</measure>
    <time_frame>baseline and at 6 month</time_frame>
    <description>Evaluate by EuroQOL test, is a standardised measure of health status. Description of the state of health in five dimensions (mobility, self-car, usual activities, pain/discomfort and anxiety/depression), each o wich is defined with three levels of severity, as measured by a Likert scale type (no problems, some problems and many problems or inability to activity).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Obstructive Sleep Apnea (OSA)</condition>
  <arm_group>
    <arm_group_label>Diagnostic Randomizing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomizing to start with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic Randomizing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA) or Standard Polysomnography (PSG)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home Respiratory Polygraphy (APNIA)</intervention_name>
    <description>Randomizing to start with home respiratory polygraphy (APNIA)</description>
    <arm_group_label>Diagnostic Randomizing</arm_group_label>
    <other_name>Validity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Polysomnography (PSG)</intervention_name>
    <description>Randomizing to start with Standard Polysomnography (PSG)</description>
    <arm_group_label>Diagnostic Randomizing</arm_group_label>
    <other_name>Validity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home Respiratory Polygraphy (APNIA)</intervention_name>
    <description>Randomizing for therapeutic decision taken with home respiratory polygraphy (APNIA)</description>
    <arm_group_label>Therapeutic Randomizing</arm_group_label>
    <other_name>Effectiveness</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Polysomnography (PSG)</intervention_name>
    <description>Randomizing for therapeutic decision taken with Standard Polysomnography (PSG)</description>
    <arm_group_label>Therapeutic Randomizing</arm_group_label>
    <other_name>Effectiveness</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women over 18 years to 75 years old, with clinical suspicion of OSA

          -  Written informed consent signed

        Exclusion Criteria:

          -  Psycho-Physical inability to perform the study at home

          -  Presence of insomnia or depressive syndrome

          -  Patient with malformation syndromes, Down syndrome and neuromuscular diseases

          -  Cardiovascular, cerebrovascular or respiratory disease exacerbated.

          -  Previous Positive continuous pressure (CPAP ) treatment or surgery for OSA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquin Duran-Cantolla</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Araba</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eduardo Anitua-Aldecoa</last_name>
    <role>Principal Investigator</role>
    <affiliation>BTI Technology Institute SL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joaquin Duran-Cantolla, MD</last_name>
    <phone>+34945007043</phone>
    <email>joaquin.durancantolla@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Gasteiz / Vitoria</city>
        <state>Araba</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquin Duran-Cantolla, MD</last_name>
      <phone>+34945007043</phone>
      <email>joaquin.durancantolla@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Araba</name>
      <address>
        <city>Gasteiz / Vitoria</city>
        <state>Araba</state>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquin Duran-Cantolla, MD</last_name>
      <phone>+34945007043</phone>
      <email>joaquin.durancantolla@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo Anitua-Aldecoa, DD,MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Egea-Santaolalla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>1. Dur√°n-Cantolla J, Puertas FJ, Pin G y el Grupo Espa√±ol de Sue√±o (GES).Documento de consenso nacional sobre el SAHS. Arch Bronconumol 2005;41(n¬∫4):1-110.</citation>
  </reference>
  <reference>
    <citation>Lloberes P, Dur√°n-Cantolla J, Mart√≠nez-Garc√≠a M√Å, Mar√≠n JM, Ferrer A, Corral J, Masa JF, Parra O, Alonso-√Ålvarez ML, Ter√°n-Santos J. Diagnosis and treatment of sleep apnea-hypopnea syndrome. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol. 2011 Mar;47(3):143-56. doi: 10.1016/j.arbres.2011.01.001. English, Spanish. Erratum in: Arch Bronconeumol. 2011 Jul;47(7):378.</citation>
    <PMID>21398016</PMID>
  </reference>
  <reference>
    <citation>Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, Rapoport DM, Redline S, Resnick HE, Robbins JA, Shahar E, Unruh ML, Samet JM. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009 Aug;6(8):e1000132. doi: 10.1371/journal.pmed.1000132. Epub 2009 Aug 18.</citation>
    <PMID>19688045</PMID>
  </reference>
  <reference>
    <citation>Dur√°n Cantolla J, Esnaola Sukia S, Rubio Aramendi R, Egea Santaolalla C. [Validity of a portable recording system (MESAM IV) for the diagnosis of sleep apnea syndrome]. Arch Bronconeumol. 1994 Aug-Sep;30(7):331-8. Spanish.</citation>
    <PMID>7952834</PMID>
  </reference>
  <reference>
    <citation>Esnaola S, Dur√°n J, Infante-Rivard C, Rubio R, Fern√°ndez A. Diagnostic accuracy of a portable recording device (MESAM IV) in suspected obstructive sleep apnoea. Eur Respir J. 1996 Dec;9(12):2597-605.</citation>
    <PMID>8980975</PMID>
  </reference>
  <reference>
    <citation>Parra O, Garc√≠a-Esclasans N, Montserrat JM, Garc√≠a Eroles L, Ru√≠z J, L√≥pez JA, Guerra JM, Sope√±a JJ. Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies? Eur Respir J. 1997 Aug;10(8):1720-4.</citation>
    <PMID>9272909</PMID>
  </reference>
  <reference>
    <citation>Jim√©nez G√≥mez A, Golpe G√≥mez R, Carpizo Alfayate R, de la Roza Fern√°ndez C, Fern√°ndez Rozas S, Garc√≠a P√©rez MM. [The validation of a portable 3-channel recording system (Oxyflow, Edentec) for the diagnosis of the sleep apnea syndrome]. Arch Bronconeumol. 2000 Jan;36(1):7-12. Spanish.</citation>
    <PMID>10726178</PMID>
  </reference>
  <reference>
    <citation>Calleja JM, Esnaola S, Rubio R, Dur√°n J. Comparison of a cardiorespiratory device versus polysomnography for diagnosis of sleep apnoea. Eur Respir J. 2002 Dec;20(6):1505-10.</citation>
    <PMID>12503711</PMID>
  </reference>
  <reference>
    <citation>N√∫√±ez R, Rey de Castro J, Socarr√°s E, Calleja JM, Rubio R, Aizpuru F, Dur√°n-Cantolla J. [Validation study of a polygraphic screening device (BREAS SC20) in the diagnosis of sleep apnea-hypopnea syndrome]. Arch Bronconeumol. 2003 Dec;39(12):537-43. Spanish.</citation>
    <PMID>14636489</PMID>
  </reference>
  <reference>
    <citation>Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hern√°ndez-Blasco L, Monasterio C, Alonso A, Chiner E, Rubio M, Garcia-Ledesma E, Cacelo L, Carpizo R, Sacristan L, Salord N, Carrera M, Sancho-Chust JN, Embid C, V√°zquez-Polo FJ, Negr√≠n MA, Montserrat JM. Effectiveness of home respiratory polygraphy for the diagnosis of sleep apnoea and hypopnoea syndrome. Thorax. 2011 Jul;66(7):567-73. doi: 10.1136/thx.2010.152272. Epub 2011 May 20.</citation>
    <PMID>21602541</PMID>
  </reference>
  <reference>
    <citation>Masa JF, Corral J, Pereira R, Duran-Cantolla J, Cabello M, Hern√°ndez-Blasco L, Monasterio C, Alonso A, Chiner E, Zamorano J, Aizpuru F, Montserrat JM; Spanish Sleep Network. Therapeutic decision-making for sleep apnea and hypopnea syndrome using home respiratory polygraphy: a large multicentric study. Am J Respir Crit Care Med. 2011 Oct 15;184(8):964-71. doi: 10.1164/rccm.201103-0428OC. Epub 2011 Jul 7. Erratum in: Am J Respir Crit Care Med. 2012 Jan 15;185(2):233.</citation>
    <PMID>21737584</PMID>
  </reference>
  <reference>
    <citation>Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, Friedman L, Hirshkowitz M, Kapen S, Kramer M, Lee-Chiong T, Loube DL, Owens J, Pancer JP, Wise M. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005 Apr;28(4):499-521. Review.</citation>
    <PMID>16171294</PMID>
  </reference>
  <reference>
    <citation>Dur√°n Cantolla J, Amilibia Alonso J, Barb√© Ill√° F, Capote Gil F, Gonz√°lez-Mangado N, Jim√©nez G√≥mez A, Mar√≠n Trigo JM, Masa Jim√©nez JF, Montserrat Canal JM, Ter√°n Santos J. [Availability of technical resources for diagnosis and treatment of sleep obstructive apnea syndrome in state hospitals in Spain]. Arch Bronconeumol. 1995 Nov;31(9):463-9. Spanish.</citation>
    <PMID>8520819</PMID>
  </reference>
  <reference>
    <citation>Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest. 1993 Jan;103(1):30-6.</citation>
    <PMID>8417909</PMID>
  </reference>
  <reference>
    <citation>Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, Khajehdehi A, Shapiro CM. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008 May;108(5):812-21. doi: 10.1097/ALN.0b013e31816d83e4.</citation>
    <PMID>18431116</PMID>
  </reference>
  <reference>
    <citation>Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91.</citation>
    <PMID>10507956</PMID>
  </reference>
  <reference>
    <citation>Ragette R, Wang Y, Weinreich G, Teschler H. Diagnostic performance of single airflow channel recording (ApneaLink) in home diagnosis of sleep apnea. Sleep Breath. 2010 Jun;14(2):109-14. doi: 10.1007/s11325-009-0290-2. Epub 2009 Aug 28.</citation>
    <PMID>19714380</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2016</study_first_submitted>
  <study_first_submitted_qc>January 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2018</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Araba</investigator_affiliation>
    <investigator_full_name>Joaquin Duran-Cantolla, MD</investigator_full_name>
    <investigator_title>Principal Investigator. MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Home Respiratory Polygraphy</keyword>
  <keyword>Standard Polysomnography</keyword>
  <keyword>Validity</keyword>
  <keyword>Cost-effectiveness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

